MeiraGTx Holdings MGTX
NASDAQ MGTX
$9.62 +0.13 (+1.37%)
At close: Nov 10, 2026 · 4:00 PM EST

MeiraGTx Holdings (MGTX) Equity Income (2026)

Updated

MeiraGTx Holdings' Equity Income was -$71.9 million in Q2 2026.

Analysis

MeiraGTx Holdings (MGTX) Equity Income (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -19.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 MeiraGTx Holdings 906.09 Mn 610.82 Mn 314.27 Mn -71.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -71.90 Mn
API Access

MeiraGTx Holdings Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=MGTX&period=max&api_key=YOUR_API_KEY